title: Cancer drugs fund receives boost but will no longer fund "overpriced" drugs.
authors.affiliation: London.
authors.forename: Nigel
authors.initials: N
authors.lastname: Hawkes
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics*; D016527:Drug Costs; D004739:England; D005380:Financing, Government / Q000191:economics*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D013222:State Medicine
chemical_list: D000970:Antineoplastic Agents